Research Project

Project Title:	Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy (APPEAR)
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Immune glomerulopathies
Project Summary:	The study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in complement 3 glomerulopathy.
Lead principal investigator(s):	Giuseppe Remuzzi, Bergamo
Co-investigator(s):	Erica Daina, Bergamo
Project Period:	07/2021 - 08/2023